Author Topic: POIS 2021-2022 NORD RESEARCH STUDY  (Read 56131 times)

demografx

  • Administrator
  • Hero Member
  • *****
  • Posts: 5732
  • All of us working together to defeat POIS!
Re: POIS 2021-2022 NORD RESEARCH STUDY
« Reply #420 on: November 19, 2021, 05:24:13 PM »

Has anyone any idea around when will the study restart considering everything?


A message from our POIS research team

We appreciate the patience of the POIS community, particularly given the long wait everyone endured to even get the project funded in the first place. We are still working on the administrative and institutional approvals that are needed to restart after the pandemic. While we’d love to give a definitive answer on when those roadblocks will be cleared, unfortunately, the timeline is out of our hands as we work through multiple different offices and institutions. That said, our commitment to the research has not changed: the project will get done, even if it has been delayed much longer than any of us would have liked.
« Last Edit: November 19, 2021, 06:31:10 PM by demografx »
10 years of significant POIS-reduction, treatment consisting of daily (365 days/year) testosterone patches.

TRT must be checked out carefully with your doctor due to fertility, cardiac and other risks.

40+ years of severe 4-days-POIS, married, raised a family, started/ran a business

demografx

  • Administrator
  • Hero Member
  • *****
  • Posts: 5732
  • All of us working together to defeat POIS!
Re: POIS 2021-2022 NORD RESEARCH STUDY
« Reply #421 on: November 19, 2021, 06:27:01 PM »

Some forum members have expressed difficulty in accessing the newspaper article  link about our POIS Research Study, so here is a text version of that 2019 article.



Crowdfunded grant will help UNL researcher study sex-related condition
      By CHRIS DUNKER Lincoln Journal Star Jun 26, 2019 Updated Jun 27, 2019




Dr. Tierney Lorenz, our
POISCenter-funded
Research Study 2021-2022
Principal Investigator


Hundreds of millions of dollars slated for research flow into the University of Nebraska-Lincoln each year from federal agencies like the National Science Foundation and the U.S. Department of Agriculture.
Multimillion-dollar research projects that center on creating new materials that will make computers even faster or to study drug addiction in rural areas are a large part of UNL's $308 million in research expenditures this year.
But there are also research grants that fly under the radar while also advancing understanding of the human condition.

Take a recent grant awarded to UNL researcher and assistant professor of psychology Tierney Lorenz from the National Organization of Rare Disorders to study a little-known condition affecting men following ejaculation.
Through a crowdfunded grant totaling $31,000, Lorenz and California-based neuroscientist and sex researcher Nicole Prause will study post-orgasmic illness syndrome, or POIS, the rapid onset of flu-like symptoms in men at the conclusion of sex.
"It's a fairly rare condition, and it hasn't gotten much clinical attention," Lorenz said of the disease, which is commonly marked by coughing and sneezing, sore throats and stuffy noses as well as other physical symptoms.
Some men have reported cognitive difficulties such as a loss of attention span or memory loss. Symptoms can last for a few hours or as long as a week, Lorenz added.

“It's not life-threatening in any way, but these guys can get pretty sick, and the flu can take a big chunk out of their life," she said.
An online community for men who suffer from the disorder raised the funds and worked with the nonprofit National Organization for Rare Disorders in asking for research proposals. Lorenz and Prause's study of the "Autonomic, endocrine, and immune mediators of post-orgasmic illness syndrome" was accepted earlier this year.
The researchers believe a better understanding of the disorder could further larger insight into the physiology of the human orgasm, which could improve sexual health for all, even those without the condition.

It also signals a new track of research at UNL. Lorenz, who just completed her first year on faculty, is the director of the Women, Immunity and Sexual Health lab, which studies how sexual behavior in women affects their immune and endocrine functions, while also providing help to survivors of sexual trauma through basic science and clinical research.
Lorenz, as well as Prause, previously conducted research at the Kinsey Institute at Indiana University Bloomington, where she studied the suppression of women's immune systems during ovulation -- an evolutionary change to prevent the immune system from attacking sperm cells or a zygote -- and whether sexual activity modulates that suppression.
She said the forthcoming POIS study, which will largely take place in Prause's lab in California, is a continuation of her work understanding the larger immune effects of the sexual response cycle.
"It's a really rare condition in which the whole system kind of goes haywire," Lorenz said, "but when we understand how something breaks down, it also helps us understand how it works.”






Dr. Nicole Prause
POISCenter-funded NORD Study’s researcher/co-Investigator



For those of you who haven’t seen the original announcement.


Our POIS Research Team


https://rarediseases.org/for-clinicians-and-researchers/research-opportunities/research-grant-recipients/
(See 2018 Research Grant Recipients)

From NORD:

Dear Demo,

We are very pleased to tell you that NORD's Medical Advisory Committee has selected the following POIS research project for funding:

Principal Investigator: Tierney Lorenz, PhD
Institution: University of Nebraska-Lincoln
Project Title:  Autonomic, endocrine, and immune mediators of Post-Orgasmic Illness Syndrome.

With funding from POISCenter.com

Congratulations!  We recognize that this has been a long journey for the POIS community and are so excited that this grant funding will be used to support Dr. Lorenz and her team in advancing the field of POIS research.

Research Administration
National Organization of Rare Disorders (NORD)





Dr. Tierney Lorenz, our Primary Investigator



Dr. Nicole Prause, our Co-Investigator




The POIS data will be collected at Dr. Prause’s lab (Liberos LLC) in Los Angeles, but both Dr. Lorenz and Dr. Prause will be analyzing it.
www.liberoscenter.com
10 years of significant POIS-reduction, treatment consisting of daily (365 days/year) testosterone patches.

TRT must be checked out carefully with your doctor due to fertility, cardiac and other risks.

40+ years of severe 4-days-POIS, married, raised a family, started/ran a business

Limejuice

  • Global Moderator
  • Full Member
  • *****
  • Posts: 193
Re: POIS 2021-2022 NORD RESEARCH STUDY
« Reply #422 on: November 20, 2021, 10:24:53 AM »

Has anyone any idea around when will the study restart considering everything?


A message from our POIS research team

We appreciate the patience of the POIS community, particularly given the long wait everyone endured to even get the project funded in the first place. We are still working on the administrative and institutional approvals that are needed to restart after the pandemic. While we’d love to give a definitive answer on when those roadblocks will be cleared, unfortunately, the timeline is out of our hands as we work through multiple different offices and institutions. That said, our commitment to the research has not changed: the project will get done, even if it has been delayed much longer than any of us would have liked.

The commitment from the research team is encouraging and comforting. Thank you for sharing!

Limejuice

  • Global Moderator
  • Full Member
  • *****
  • Posts: 193
Re: POIS 2021-2022 NORD RESEARCH STUDY
« Reply #423 on: November 20, 2021, 05:32:17 PM »
:)  A little forum humor :)



The commitment from the research team is encouraging and comforting. Thank you for sharing!


Thank you for that, Limejuice!

Your Forum Contributions have been greatly appreciated. Since the Civil War years! (Remember Ulysses Grant and his bloodletting to relieve POIS?) ;D

All the very best,
Demo




 ;D
We will never forget.
« Last Edit: November 21, 2021, 02:55:08 AM by demografx »

demografx

  • Administrator
  • Hero Member
  • *****
  • Posts: 5732
  • All of us working together to defeat POIS!
Re: POIS 2021-2022 NORD RESEARCH STUDY
« Reply #424 on: November 24, 2021, 12:09:30 AM »

From our POIS Study (2021-2022) Researcher, Dr. Nicole Prause!

Subject: New podcast on POIS


https://www.sexandpsychology.com/blog/podcast/episode-60-the-science-of-orgasms/?fbclid=IwAR0dpuxY1HFGruaie-wQhvVSfCdf3SQz1vBIEd7007y6Cyvr_MmF5t_LLXQ

“We talk POIS just after the break. I think his podcast is one of the top 10 in psychology in itunes?”

Thanks, Dr Prause!


Dr. Nicole Prause, our POIS Study Co-Investigator

Dr. Tierney Lorenz is our Primary Investigator

10 years of significant POIS-reduction, treatment consisting of daily (365 days/year) testosterone patches.

TRT must be checked out carefully with your doctor due to fertility, cardiac and other risks.

40+ years of severe 4-days-POIS, married, raised a family, started/ran a business

demografx

  • Administrator
  • Hero Member
  • *****
  • Posts: 5732
  • All of us working together to defeat POIS!
Re: POIS 2021-2022 NORD RESEARCH STUDY
« Reply #425 on: November 25, 2021, 07:59:39 PM »




POISCenter-funded NORD researcher/co-Investigator
Dr. Nicole Prause’s TedX talk on orgasm:
https://m.youtube.com/watch?v=aK-zBBSqFV4


10 years of significant POIS-reduction, treatment consisting of daily (365 days/year) testosterone patches.

TRT must be checked out carefully with your doctor due to fertility, cardiac and other risks.

40+ years of severe 4-days-POIS, married, raised a family, started/ran a business